Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Date:8/1/2013

approval of BELVIQ in Canada.

BELVIQ Additional Developments 

  • BELVIQ has been nominated for the 2013 Prix Galien USA Best Pharmaceutical Agent Award. The Prix Galien recognizes outstanding achievements in improving the human condition through the development of innovative therapies.
  • Presented a poster, Lorcaserin HCl Phase 3 Trials in Obese and Overweight Patients: Week 52 Outcomes for Those Achieving at Least 5% Weight Loss at Week 12, at the American Diabetes Association's 73rd Scientific Sessions in Chicago, Illinois.
  • The American Medical Association recognized obesity as a disease state with multiple pathophysiological aspects requiring a range of interventions to advance obesity treatment and prevention.
  • Presented a poster, Association of Changes in Glycemic- and Lipid-Related Cardiometabolic Risk Factors and Weight Loss in Pooled Lorcaserin Phase 3 Studies of Obese and Overweight Patients Without Diabetes (BLOOM and BLOSSOM), at ENDO 2013, the Endocrine Society's 95th Annual Meeting & Expo in San Francisco, California.
  • Research & Development 

  • Completed dosing in a study to evaluate the safety, tolerability and pharmacokinetic properties of BELVIQ and phentermine when administered in combination. In addition, agreed on plans with Eisai to initiate a 12-week pilot study to evaluate the co-administration of BELVIQ and phentermine.
  • Completed dosing in a Phase 1 multiple-dose clinical trial of APD811, an oral drug candidate intended for the treatment of pulmonary arterial hypertension. Arena expects to announce results from the Phase 1 program this quarter.  
  • Completed dosing in a Phase 1 clinical trial of APD334, an oral drug candidate intended for the treatment of autoimmune diseases. Preliminary results show a reduction in blood lymphocyte count, the desired benefit, and a slowing of heart rate, an undesirable adverse event seen with
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
    2. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
    3. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
    4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
    5. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
    6. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
    7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
    8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
    9. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
    10. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
    11. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... 22, 2014 Research ... addition of the  "Global Operating Room Equipment ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,An operating ... environment in a healthcare facility used to ... technically advanced equipment, which ensures patient care ...
    (Date:8/22/2014)...  Diplomat, the nation,s largest independent specialty pharmacy, ... in the 2014 Innovations in Specialty Pharmacy Competition, ... of the competition were announced in the August ... Diplomat was honored as a Top Innovator ... Through Diplomat University, the company has implemented a ...
    (Date:8/22/2014)... , Aug. 22, 2014 /CNW/ - On Aug. 20, ... , the Canadian Medical Association (CMA) voted on and ... plant material, including medicinal cannabis. Bedrocan Cannabis Corp., a ... of the CMA motion. The CMA is ... hazards associated with smoking any plant material, including medicinal ...
    Breaking Medicine Technology:Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2
    (Date:8/22/2014)... A new study of self-awareness by Kessler ... (MS) may be able to improve their self-awareness ... ahead of print on July 2 in ... Nancy D. Chiaravalloti & John DeLuca: Metacognitive knowledge ... doi: 10.3233/NRE-141113). Self-awareness is one,s ability to recognize ...
    (Date:8/22/2014)... Renal artery stenting to open blockages in ... historically been excluded from modern clinical trials, according ... in Catheterization and Cardiovascular Interventions today ... (SCAI). , University Hospitals Case Medical Center,s Sahil ... Professor of Medicine, Case Western Reserve University School ...
    (Date:8/22/2014)... Home Care Assistance of Centennial ... seniors, is proud to announce the next installment in ... will feature Dr. Suzanne Steinbaum, attending cardiologist and Director ... New York City, National Spokesperson for the American Heart ... cover the issues surrounding women and heart disease, what ...
    (Date:8/22/2014)... News) -- Many children get anxious or afraid when ... a number of ways that parents can make these ... The first step is to explain to children in ... health, said Rita John, director of the pediatric primary ... Nursing in New York City. "Children need to ...
    (Date:8/22/2014)... In the previous few years, several breakthrough treatments ... cancer. Patients who may benefit from these treatments ... abnormalities in their cancer. For example, patients whose ... gene ALK derive significant benefit from the drug ... trials are now attempting to replicate this success ...
    Breaking Medicine News(10 mins):Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4
    ... ... patients with visual impairments. , ... (PRWEB) February 3, 2010 -- Having nearly perfect vision may be attainable at any ... 20/20 vision, new corrective lens implants offer the possibility of enhanced clarity for patients young ...
    ... ... ... the human capital research firm, will host a webinar titled “Building Employee Engagement in ... February 24, 2010 at 1:00 p.m. EST. , , ,Join David Rowlee, Ph.D., ...
    ... , Feb. 2 Speedus Corp. (Nasdaq: SPDE ), ... from Nasdaq, in the form of a staff determination letter, informing the ... to the Company on December 11, 2009 to comply with ... requires the Company to maintain either (1) a minimum of $2.5 ...
    ... after they get the news, study finds , TUESDAY, Feb. ... be unnerving enough to up a man,s odds for either ... the study results didn,t surprise us," said study co-author Dr. ... Medical School. "A cancer diagnosis is an acutely distressful event, ...
    ... , NASHVILLE, Tenn. , Feb. 2 ... its common stock cash dividend for the quarter ended December ... per share, is payable on March 4, 2010 ... , Healthcare Realty Trust is a real estate investment trust that ...
    ... shocked to discover that virtually all human embryonic stem cell ... to line Petri dishes had left traces on the human ... body they likely would have been rejected by the patient,s ... approved for use in medical research, there remains a risk ...
    Cached Medicine News:Health News:HD For More Than Your TV – New Technologies Offer Patients High Definition Vision At Any Age 2Health News:Morehead Presents Webinar on “Building Employee Engagement in a University Healthcare Environment” 2Health News:Speedus Receives and Appeals Nasdaq Notice 2Health News:Prostate Cancer Diagnosis Raises Suicide Risk 2Health News:Prostate Cancer Diagnosis Raises Suicide Risk 3Health News:Healthcare Realty Trust Announces Fourth Quarter Dividend 2Health News:3-D scaffold provides clean, biodegradable structure for stem cell growth 2Health News:3-D scaffold provides clean, biodegradable structure for stem cell growth 3
    DRUGology is a source designed for primary care health providers, residents and medical students so that they may have a quick reference to treat a wide variety of conditions....
    AHFS Patient Drug Information gives you a single source for providing important information and instructions for patients on dosing, precautions, possible side effects and interactions, and more....
    ... combination of new measuring principle - Pupil ... - SLD - offers high accuracy and ... ARK-530A/510A provides ordinary measurement (3.3 mm) using ... (6 mm) using 4 points, both of ...
    ... Sorting System RSD 800 is an individually ... (additional tube type identification via cap recognition ... various sample tubes in a clearly organized ... are customized and offer high capacity. The ...
    Medicine Products: